FND, Compensation and the Convenient Theory That Financial Support Keeps People Disabled
A person is injured, develops disabling neurological symptoms, struggles to obtain answers, and enters a compensation system to recover lost income and pay for treatment. According to a paper published in Frontiers in Neurology on 1 October 2026, the resulting legal and insurance arrangements may themselves influence the person's symptoms and recovery. So far, reasonable enough: stressful claims processes can have consequences. But the paper goes considerably further, entertaining the possibility that compensation, funded medical care and continued recognition of liability can reinforce disability and undermine recovery.
The paper, Biopsychosocial interplay of personal injury insurance, legal frameworks, and functional neurological disorder: an emerging perspective on recovery and disability determinants, is a mini-review by Sekine and colleagues. It examines FND in personal injury compensation systems, primarily from an Australian perspective. It is not a clinical trial demonstrating that compensation causes disability, nor does it establish that reducing financial support improves patient outcomes. That distinction matters enormously when the subject is people's livelihoods, medical care and legal rights.
From Compensation Neurosis to Modern FND
The authors trace the relationship between unexplained neurological symptoms and financial compensation back to nineteenth-century railway accidents. Injured railway passengers and workers developed persistent symptoms that physicians struggled to explain. The resulting condition, commonly called "railway spine", became the subject of medical disagreement and legal disputes. Structural explanations gradually competed with psychological interpretations, eventually producing labels such as "accident neurosis", "litigation neurosis" and "compensation neurosis".
The paper reproduces a particularly revealing description of compensation neurosis from 1946:
"a state of mind, born out of fear, kept alive by avarice, stimulated by lawyers, and cured by a verdict"
In other words, the injured person's symptoms were supposedly sustained by greed and legal proceedings, with recovery conveniently expected once the case was settled. The authors acknowledge that research has not consistently supported recovery following settlement. Yet their review returns repeatedly to the possibility that compensation-related incentives, illness beliefs, unconscious motivations and access to financial support can contribute to continuing disability.
The terminology has changed. The overt accusation of greed has largely given way to discussions of predictive processing, symptom attention, secondary gain, maladaptive beliefs and biopsychosocial mechanisms. These are not identical concepts, and the authors explicitly distinguish FND from deliberate deception. Nevertheless, the practical question remains remarkably familiar: could the injured person's entitlement to compensation be contributing to the symptoms for which compensation is sought?
When Financial Support Becomes a Suspected Cause of Disability
One of the paper's most consequential passages concerns legal liability and continued access to funded support. The authors write:
"We argue that the ongoing acceptance of liability by the defendant for the natural course of a pre-existing vulnerability and associated provision of funded supports is disempowering for FND recovery."
That is an extraordinary proposition to introduce into a discussion of personal injury compensation. It suggests that continued recognition of liability and the provision of funded assistance may work against recovery. The authors also discuss healthcare overutilisation, the entrenchment of the sick role, personality vulnerabilities and the possibility that monetary benefits offer an escape from stressful circumstances.
None of this establishes that a particular injured person is disabled because they receive compensation. Nor does it demonstrate that limiting compensation, reducing access to healthcare or withdrawing support will improve neurological function. A person with severe, persistent disability is naturally more likely to require extensive medical care and financial assistance. The association between receiving support and remaining disabled cannot, by itself, establish which causes which.
The review cites research on healthcare utilisation and psychological factors, but it does not present direct intervention evidence demonstrating that reduced compensation improves recovery in people diagnosed with FND. Nevertheless, it considers whether narrower legal liability might be in patients' recovery interests. That moves beyond describing possible influences on symptoms and into territory with potentially serious financial and legal consequences.
The authors discuss the distinction between the legal principles sometimes called the "eggshell skull" and "crumbling skull" rules. Broadly, the former protects injured people whose pre-existing vulnerabilities make them particularly susceptible to harm, while the latter distinguishes accident-related damage from deterioration that would have occurred anyway. The review suggests that clearer limits on liability may reduce unintended harm in FND. But establishing that an individual's deterioration would have occurred independently of an accident requires evidence. An FND label and a proposed biopsychosocial mechanism cannot establish that counterfactual history on their own.
The Compensation Trap
The review identifies stressful insurance processes, administrative requirements, repeated medical assessments, stigma, disputes about legitimacy and difficulty obtaining treatment as potential barriers to recovery. These are legitimate concerns. Injured people may face substantial psychological, financial and practical burdens while trying to establish their entitlement to support.
But the authors also suggest that repeatedly discussing symptoms, seeking medical validation, receiving funded treatment and maintaining accident-related compensation claims may reinforce disability. The result is a deeply uncomfortable framework in which almost every response to injury can potentially be interpreted as part of the problem.
- Fight for compensation, and the stress of the process may worsen symptoms.
- Receive compensation, and the financial support may supposedly reinforce disability.
- Seek further medical assessment, and the search for validation may be interpreted as excessive healthcare utilisation.
- Describe persistent symptoms to doctors and lawyers, and the attention paid to those symptoms may supposedly perpetuate them.
- Remain disabled despite treatment, and continued disability may be attributed to entrenched illness beliefs, unconscious motivations or other psychosocial factors.
These are possibilities discussed within the review's theoretical framework, not findings established for every patient. But that is precisely the problem when such ideas enter medico-legal decision-making. A framework that can interpret both pursuing assistance and receiving assistance as potential contributors to disability needs exceptionally strong safeguards against circular reasoning. Otherwise, the person seeking help can find their own attempts to obtain it presented as evidence against their interests.
There is a basic distinction between demonstrating that stressful administrative processes can affect health and demonstrating that the injured person's financial entitlement is maintaining a neurological disorder. The former does not prove the latter. Treating them as interchangeable would be a serious evidentiary mistake.
The Missing Diagnosis Problem
The review strongly favours earlier FND diagnosis using positive clinical signs rather than relying exclusively on the exclusion of other conditions. It cites research suggesting that many clinicians remain unfamiliar with these signs and invokes a historical misdiagnosis figure of approximately 4%. But that figure comes from a 2005 systematic review of diagnostic revisions in patients originally labelled with conversion symptoms or hysteria. It is not a universal error rate for modern FND assessments, nor does it establish that an individual patient's diagnosis is correct.
The authors also acknowledge that positive signs may not distinguish FND from voluntary deception. Yet the larger medico-legal problem receives insufficient scrutiny: what happens when symptoms following a genuine physical injury are attributed to FND, and that attribution subsequently influences the assessment of causation, treatment necessity, future disability and compensation?
A functional diagnosis does not establish that every symptom has the same origin. It does not exclude coexisting neurological disease, establish that an accident caused no lasting physical damage, or prove that subsequent deterioration is psychologically maintained. Nor does the absence of a finding on conventional investigations establish that no relevant pathology exists. These distinctions are especially important when an insurer or defendant stands to benefit financially from attributing persistent disability to factors unrelated to the original injury.
There is an obvious asymmetry here. The review examines how patients' financial incentives might influence their symptoms and behaviour, but gives much less attention to the financial incentives of insurers, defendants and compensation administrators. An injured person may benefit from receiving compensation. An insurer may benefit from denying it. If financial incentives are considered relevant to credibility and decision-making, why should the scrutiny run primarily in one direction?
The paper also discusses surveillance, noting that footage of a claimant functioning better on a particular day may be misinterpreted as evidence of sustained work capacity. That concern is valid, but it is not unique to FND. Fluctuating ability occurs across numerous neurological, inflammatory, autoimmune and other medical conditions. A person walking on Tuesday does not prove they can work full-time on Wednesday, and a brief observation cannot establish the cause of their disability.
Where the Evidence Stops and the Theory Takes Over
The paper contains an extensive reference list, but the number of references should not be confused with direct evidence for its most consequential propositions. Historical accounts of compensation neurosis, theoretical models of symptom production, observational associations and studies of healthcare utilisation do not collectively demonstrate that restricting compensation improves FND outcomes.
Several claims deserve particular scrutiny:
- Secondary gain: The existence of a possible financial or social benefit does not demonstrate that the benefit caused or maintains a patient's symptoms.
- Symptom attention: The suggestion that discussing symptoms may worsen them does not establish that documenting disability for a legal claim causes persistent neurological impairment.
- Medical overutilisation: Frequent medical consultations may reflect unresolved symptoms, inadequate investigations, fragmented care or an incorrect diagnosis. Utilisation alone cannot distinguish these explanations.
- Pre-existing vulnerability: A history of psychological adversity or personality-related difficulties does not prove that subsequent neurological disability would have developed without the accident.
- Compensation and recovery: An association between legal proceedings and poorer health outcomes does not establish that compensation itself caused those outcomes. Injury severity, financial insecurity, disputed claims and diagnostic uncertainty may all complicate the relationship.
The review itself acknowledges a lack of empirical investigation into the influence of social contexts on FND recovery and proposes future research comparing people with similar compensable injuries who do and do not develop FND. That research agenda is revealing: important causal questions remain unanswered. Until they are answered, proposed changes to compensation systems should not be presented as though their therapeutic benefits have already been established.
There is also a problem with the way uncertainty is distributed. The review entertains the possibility that an accident may trigger symptoms while subsequent psychosocial factors maintain them. But distinguishing those contributions in an individual claimant is not a simple exercise. Without reliable evidence, the distinction can become an invitation to assign continuing disability to an increasingly speculative collection of personal vulnerabilities, expectations and motivations.
In a clinical discussion, an unsupported mechanism may be an interesting hypothesis. In a compensation dispute, the same mechanism can become an argument for reducing liability. That difference deserves considerably more attention than it receives.
When a Medical Theory Becomes a Legal Weapon
The danger is not that researchers are studying the relationship between compensation systems and health. They should. The danger arises when speculative explanations of disability are treated as established facts about individual patients, particularly where those explanations favour the party responsible for paying compensation.
Consider an injured person who develops persistent weakness, tremor, seizures or other disabling symptoms. If those symptoms are labelled FND, the review's framework offers numerous possible explanations for their persistence: attention, beliefs, stress, prior adversity, medical reinforcement, secondary gain, financial support or the legal process itself. Some may be relevant in particular cases. But merely naming them does not demonstrate that any one of them caused the patient's condition.
It is equally important to recognise what the framework can leave unresolved. Was the original injury adequately investigated? Were alternative diagnoses considered? Are the findings supporting FND sufficiently specific? Has the patient developed another condition since the original assessment? Is continued disability being attributed to psychological or social factors because those factors have actually been demonstrated, or because the medical explanation remains uncertain?
These are not minor academic objections. They determine whether an injured person receives treatment, income replacement, rehabilitation and long-term support. A medical opinion that affects those decisions should be based on the patient's documented clinical evidence, not merely on the availability of a theory explaining why compensation might be bad for them.
The authors are not explicitly recommending that every patient diagnosed with FND lose compensation. They acknowledge the benefits of timely specialist care, wage replacement and rehabilitation support. But they also advance the possibility that limiting liability and funded support could benefit recovery. That proposition deserves direct outcome evidence before anyone uses it to justify restricting assistance.
Ultimately, the review illustrates how easily the language of patient recovery can overlap with arguments for reducing financial responsibility. The same proposed intervention can be described as avoiding iatrogenic harm or as limiting an insurer's liability. Those are not necessarily equivalent objectives, and evidence supporting one cannot simply be assumed to support the other.
Being injured does not make someone entitled to unlimited compensation. But being diagnosed with FND does not make them responsible for their own disability, either. Causation, medical necessity and legal liability require evidence. A diagnosis should not become a shortcut around that requirement.
Patients should not have to prove that they are sufficiently disabled to deserve support while simultaneously defending themselves against the suggestion that seeking or receiving that support is what keeps them disabled. If a compensation system genuinely wants to improve recovery, it should investigate injuries thoroughly, make defensible decisions, provide appropriate care and avoid unnecessary administrative harm.
And if someone proposes that paying injured people less will help them recover, the burden should be on that person to produce convincing evidence. Not another theory about what the patient might unconsciously want.
References
- Sekine ER et al. (2026). Biopsychosocial interplay of personal injury insurance, legal frameworks, and functional neurological disorder. Frontiers in Neurology. Primary article reviewed.
- Sekine ER et al. (2025). Biopsychosocial prognostic indicators in functional neurological disorder: a systematic review. Journal of Psychosomatic Research. Discusses limitations in the evidence concerning biopsychosocial prognostic factors.
- Stone J et al. (2005). Systematic review of misdiagnosis of conversion symptoms and hysteria. BMJ. Historical evidence frequently cited in discussions of FND diagnostic error.
- McLoughlin C et al. (2024). Iatrogenic harm in functional neurological disorder. Brain. Review of potential healthcare-related harms.
- Hall RC and Hall RC (2012). Compensation neurosis: a too quickly forgotten concept? Journal of the American Academy of Psychiatry and the Law. Historical and psychiatric discussion of compensation neurosis.
- Mendelson G (1995). Compensation neurosis revisited: outcome studies of the effects of litigation. Journal of Psychosomatic Research. Examines the relationship between litigation outcomes and recovery.
- Phillips W (2021). Functional neurological disorders in personal injury. BMJ Neurology Open. Discusses diagnostic and medico-legal issues surrounding FND in personal injury claims.
- Kilgour E et al. (2015). Interactions between injured workers and insurers in workers' compensation systems: a systematic review of qualitative research literature. Journal of Occupational Rehabilitation. Examines injured workers' experiences of insurance processes.
This post explores a hypothesis. It should not be read as an established fact or settled scientific conclusion.